LEVITT ROY C has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1993. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are INNER MONGOLIA HUAXI BIOTECHNOLOGY CO LTD, MCCLOSKEY JENNY COLLEEN and HIPRA SCIENT S L U.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Hungary | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Syringes | |
#6 | Climate change adaptation technologies | |
#7 | Measuring nuclear radiation |
# | Name | Total Patents |
---|---|---|
#1 | Levitt Roy C | 12 |
#2 | Levitt Jr Roy C | 2 |
Publication | Filing date | Title |
---|---|---|
AU2013270447A1 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors | |
EP2068889A1 | Anakinra for use in the treatment of bronchiolitis obliterans syndrome | |
EP2851064A2 | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors | |
WO9414085A1 | Localizing source of charged particles using electric field |